Executive Vice President, AstraZeneca & Head of MedImmune
Dr. Bahija Jallal is Executive Vice President of AstraZeneca and head of MedImmune, the global biologics research and development organization. She is a member of AstraZeneca’s senior executive team reporting to the CEO. Dr. Jallal joined MedImmune in March 2006.
Dr. Jallal is a member of the Board of Trustees of The Johns Hopkins University and the Board of Directors of the University of Maryland Health Sciences Research Park Corporation.
Dr. Jallal has authored over 70 peer-reviewed publications and has more than 15 patents. She is a member of the American Association of Cancer Research, the American Association of Science and the Pharmacogenomics Working Group and is the President of the Board of Directors for the Association of Women in Science.